SouthState’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
SouthState's BBIO Position: Q3 2026 in Review
SouthState held its BridgeBio Pharma (BBIO) position steady in Q3 2026 at 16 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.
SouthState first reported a position in BBIO in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.22K in Q4 2025. 348 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- SouthState held 16 shares of BridgeBio Pharma worth $1.05K as of Q3 2026.
- SouthState left its BridgeBio Pharma share count unchanged in Q3 2026.
- BridgeBio Pharma made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1126 holding.
- SouthState first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 7 quarters since.
- SouthState's BridgeBio Pharma position peaked at $1.22K in Q4 2025.
- 348 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.